The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
The number of anesthesiology residents applying to pain medicine decreased 45 percent from 2019 to 2023, according t ...
The study found that between 2019 and 2023, there was an overall 45% decline in anesthesia-based applicants to pain medicine fellowships.
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.